Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?

To: Frederick Langford who wrote (1678)	1/5/1999 2:28:00 PM
From: Bucky Katt	Respond to of 57584

FDA approves first behavioral drugs for dogs WASHINGTON, Jan 5 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it had approved two drugs to treat behavioral problems in dogs -- the first such drugs for neurotic canines. The FDA said Clomicalm tablets sold by Novartis Animal Health U.S. Inc , could be used to treat separation anxiety in dogs. The other drug, Anipryl made by Pfizer Inc (NYSE:PFE - news), could be used to control clinical signs associated with canine Cognitive Dysfunction Syndrome. Separation anxiety occurs when the owner of a dog or someone the dog is attached to leaves the animal. Dogs may show annoying symptoms such as barking, destructive behavior such as ripping up rugs or sofas, excessive salivation or urination and defecation. The FDA said clinical trials of Clomicalm on dogs older than six months, when used with behavior modification training, showed a reduction in the symptoms. Anipryl tablets treated CDS, an age-related deterioration in which a dog's cognitive skills are affected. Such changes in the dog's behavior would include disorientation, decreased activity, loss of house training and less or altered greeting behavior. Both of the drugs are available in tablet form and only on the order of a veterinarian, the FDA said. Next, viagra for "old dogs" Ah, the marketing dept.!!!! We live in strange times.... --------------------------------------------------------------------------------